{"meta":{"query_hash":"ee0a2d82d17d","filters":{"venue":"Zhongguo aizheng zazhi"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ee0a2d82d17d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Zhongguo+aizheng+zazhi"},"results":[{"id":"W2353777016","doi":"","title":"Expression of MEK-1 in regulation of αV integrin and E-cadherin of MCF-7 breast cancer cells","year":2003,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"MEK inhibitor; Integrin; MAPK/ERK pathway; Cadherin; MCF-7; Phosphorylation; Cell biology; Transfection; Chemistry; Cancer research; Molecular biology; Cancer cell; Biology; Cell; Cancer; Gene; Biochemistry; Human breast; Genetics","score_opus":0.0075772778683541086,"score_gpt":0.22189310087476866,"score_spread":0.21431582300641455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2353777016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339783,0.0021494573,0.0014942953,0.00012795086,0.00002683096,0.00001710723,0.00021294487,0.00004057362,0.0025329683],"genre_scores_gemma":[0.9936646,0.0011234594,0.0013938808,0.000038674865,0.0000046547043,0.00002005083,0.0003883594,0.00000676668,0.0033596023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.0000086481405,0.000004542046,0.000010626707,0.000019756957,0.000022436318],"domain_scores_gemma":[0.99997556,0.000004204945,0.000005404944,0.0000027597646,0.0000052954415,0.000006918331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006304268,0.00025670914,0.00010682755,0.00011558853,0.00013246319,0.0001802537,0.00011685681,0.0001362782,0.00088918826],"category_scores_gemma":[0.00005076347,0.000102846425,0.00014901173,0.000057610272,0.00009696263,0.00011093271,0.00009684693,0.0003445016,0.00028749174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059205748,0.000016833053,0.00015384742,0.000029714953,0.0000018600045,0.000028789298,0.000009044097,0.00003419391,0.9987167,0.00012824875,0.000032304317,0.0007891744],"study_design_scores_gemma":[0.000014069583,0.00012428715,0.0034812246,0.0000054025363,0.000011008474,0.00018582454,0.000023289787,0.0008303303,0.99248123,0.00004381983,0.0027973333,0.0000022686438],"about_ca_topic_score_codex":0.0006815406,"about_ca_topic_score_gemma":0.0010607541,"teacher_disagreement_score":0.00088918826,"about_ca_system_score_codex":0.000307069,"about_ca_system_score_gemma":0.00015739363,"threshold_uncertainty_score":0.0029746294},"labels":[],"label_agreement":null},{"id":"W2372010367","doi":"","title":"BCL-6,CD10 and BCL-2 protein expression in B-cell Non-Hodgkin's lymphoma and its clinicopathologic significance","year":2006,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Lymphoma; Germinal center; Mantle cell lymphoma; Lymphoid hyperplasia; Pathology; Mantle zone; Follicular lymphoma; Diffuse large B-cell lymphoma; MALT lymphoma; Follicular hyperplasia; Marginal zone; B cell; Lymphoplasmacytic Lymphoma; Lymph node; Immunohistochemistry; Medicine; Cancer research; Antibody; Immunology; Waldenstrom macroglobulinemia","score_opus":0.011522928662274588,"score_gpt":0.25029437823767586,"score_spread":0.23877144957540128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2372010367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863225,0.0009404875,0.000080205915,0.0000145864815,0.0000022091795,0.0000027660367,0.0000142970985,0.0000031055672,0.00030998743],"genre_scores_gemma":[0.99952114,0.00024549937,0.00006952367,0.000004666163,0.0000045805127,0.00000311475,0.000029202092,4.914072e-7,0.000121784164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989414,0.000024711822,0.000011442787,0.000016826385,0.000031127,0.000021737489],"domain_scores_gemma":[0.99979204,0.00005457351,0.000068190486,0.000011997404,0.0000349579,0.000038296508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047095146,0.00012742788,0.00007123469,0.0009579354,0.00014825929,0.00017984785,0.00014587495,0.00017331197,0.0006242147],"category_scores_gemma":[0.00050431455,0.00011661025,0.00006793719,0.0003744815,0.00039584527,0.0002343815,0.00012546714,0.00010010208,0.000096698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029485862,0.000033038676,0.95543265,0.00007474542,0.000025781857,0.003184069,0.00025782167,0.000084953856,0.030001452,0.00007677247,0.00012428504,0.0104096085],"study_design_scores_gemma":[0.000031102183,0.00016565535,0.968212,0.00001755389,0.000054515072,0.023358546,0.0003477244,0.00050979713,0.005436459,0.00013867723,0.0017207,0.0000073050837],"about_ca_topic_score_codex":0.0010569119,"about_ca_topic_score_gemma":0.0012751664,"teacher_disagreement_score":0.0010569119,"about_ca_system_score_codex":0.00021267595,"about_ca_system_score_gemma":0.00012397295,"threshold_uncertainty_score":0.0024906397},"labels":[],"label_agreement":null},{"id":"W2380392281","doi":"","title":"Novel therapeutic strategies for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways","year":2009,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Bevacizumab; Pancreatic cancer; Vascular endothelial growth factor; Oncology; Cetuximab; Epidermal growth factor receptor; Sunitinib; Internal medicine; Sorafenib; EGFR inhibitors; Epidermal growth factor; Gefitinib; Cancer; Pharmacology; Chemotherapy; Hepatocellular carcinoma; Colorectal cancer; Receptor","score_opus":0.04308598512289617,"score_gpt":0.31992339374826745,"score_spread":0.27683740862537126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2380392281","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034933306,0.940969,0.008261146,0.00570012,0.00059395167,0.00013302098,0.000046154964,0.00006334336,0.009300013],"genre_scores_gemma":[0.16280717,0.8157857,0.012260736,0.0019783957,0.0008493375,0.00016075809,0.00011298991,0.000013194141,0.006031669],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99990475,0.000033587607,0.000007635315,0.0000139530775,0.000022855444,0.00001723312],"domain_scores_gemma":[0.99992836,0.000025589748,0.000015864765,0.0000038609223,0.000011489049,0.000014945627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054541515,0.00039223203,0.000495259,0.0008822805,0.0001825707,0.0006337705,0.0003480726,0.000562345,0.0026586573],"category_scores_gemma":[0.00021704243,0.000109853,0.00039812826,0.00040219125,0.00044520802,0.00095274346,0.00040990746,0.00094193325,0.00046985265],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006546468,0.00083570083,0.0011536137,0.0048533133,0.00012908535,0.0019937903,0.00018808532,0.0010293795,0.0556024,0.008623593,0.006238774,0.91869754],"study_design_scores_gemma":[0.0027015219,0.007037706,0.015180672,0.0024448487,0.0009081372,0.02214045,0.0008313659,0.0026696676,0.07341631,0.019974133,0.85258293,0.00011224841],"about_ca_topic_score_codex":0.00027430948,"about_ca_topic_score_gemma":0.0009904957,"teacher_disagreement_score":0.0026586573,"about_ca_system_score_codex":0.0004292531,"about_ca_system_score_gemma":0.00042061132,"threshold_uncertainty_score":0.0088941455},"labels":[],"label_agreement":null}]}